SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DewDiligence_on_SI who wrote (606145)8/26/2016 4:50:49 PM
From: Jack Be Quick1 Recommendation

Recommended By
Alan Smithee

  Read Replies (1) of 793669
 
Here’s a good read that contains educated speculation on what’s wrong with Teva’s generic-EpiPen application: seekingalpha.com
Well, I read it. I'll admit, I read it quickly. I don't see much speculation on what's wrong or right with Teva's generic EpiPen. I do see a lot of speculation about how many hoops and how much folderol the FDA will make the applicants dance through for FDA's own bureaucratic reasons. Just curious, what specifically in this link that you've provided makes you feel all warm and happy about the FDA wrt the generic EpiPen application?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News